[go: up one dir, main page]

GB9225860D0 - Novel treatment - Google Patents

Novel treatment

Info

Publication number
GB9225860D0
GB9225860D0 GB929225860A GB9225860A GB9225860D0 GB 9225860 D0 GB9225860 D0 GB 9225860D0 GB 929225860 A GB929225860 A GB 929225860A GB 9225860 A GB9225860 A GB 9225860A GB 9225860 D0 GB9225860 D0 GB 9225860D0
Authority
GB
United Kingdom
Prior art keywords
novel treatment
novel
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929225860A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB929225860A priority Critical patent/GB9225860D0/en
Publication of GB9225860D0 publication Critical patent/GB9225860D0/en
Priority to JP6513936A priority patent/JPH08504432A/en
Priority to PCT/GB1993/002514 priority patent/WO1994013292A1/en
Priority to EP94902046A priority patent/EP0673248A1/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB929225860A 1992-12-11 1992-12-11 Novel treatment Pending GB9225860D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB929225860A GB9225860D0 (en) 1992-12-11 1992-12-11 Novel treatment
JP6513936A JPH08504432A (en) 1992-12-11 1993-12-08 Potassium channel activator useful in therapy
PCT/GB1993/002514 WO1994013292A1 (en) 1992-12-11 1993-12-08 Potassium channel activators for use in therapy
EP94902046A EP0673248A1 (en) 1992-12-11 1993-12-08 Potassium channel activators for use in therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929225860A GB9225860D0 (en) 1992-12-11 1992-12-11 Novel treatment

Publications (1)

Publication Number Publication Date
GB9225860D0 true GB9225860D0 (en) 1993-02-03

Family

ID=10726441

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929225860A Pending GB9225860D0 (en) 1992-12-11 1992-12-11 Novel treatment

Country Status (4)

Country Link
EP (1) EP0673248A1 (en)
JP (1) JPH08504432A (en)
GB (1) GB9225860D0 (en)
WO (1) WO1994013292A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9425502D0 (en) * 1994-12-17 1995-02-15 Smithkline Beecham Plc Novel receptor
US6245893B1 (en) 1994-12-17 2001-06-12 Smithkline Beecham P.L.C. Receptor that binds anti-convulsant compounds
DE19707656A1 (en) * 1997-02-26 1998-08-27 Hoechst Ag Sulphonamide-substituted fused 7-ring compounds, processes for their preparation, their use as medicaments or diagnostic agents and pharmaceutical preparations containing them
US6333349B1 (en) 1997-02-26 2001-12-25 Aventis Pharma Deutschland Gmbh Sulfonamide-substituted fused 7-membered ring compounds, their use as a medicament, and pharmaceutical preparations comprising them
GB9909792D0 (en) 1998-12-04 1999-06-23 Cambridge Bioclinical Limited Potassium channel activators and their use
SMT201700456T1 (en) 2009-07-27 2017-11-15 Gilead Sciences Inc Fused heterocyclic compounds as ion channel modulators
JP5858586B2 (en) 2010-07-02 2016-02-10 ギリアード サイエンシーズ, インコーポレイテッド Fused heterocyclic compounds as ion channel modulators
CN102141055B (en) * 2011-02-25 2013-12-04 南京高精船用设备有限公司 Hydraulic-control throttling hydraulic valve and application thereof
TWI577670B (en) 2011-05-10 2017-04-11 基利科學股份有限公司 Fused heterocyclic compounds as ion channel modulators
TWI478908B (en) 2011-07-01 2015-04-01 Gilead Sciences Inc Fused heterocyclic compound as ion channel regulator
NO3175985T3 (en) 2011-07-01 2018-04-28

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8414987D0 (en) * 1984-06-12 1984-07-18 Beecham Group Plc Active compounds
PT89205B (en) * 1987-12-14 1993-06-30 Beecham Group Plc PROCESS FOR THE PREPARATION OF INDUCED DERIVATIVES
GB8730051D0 (en) * 1987-12-23 1988-02-03 Beecham Group Plc Novel compounds
GB8812765D0 (en) * 1988-05-28 1988-06-29 Beecham Group Plc Novel compounds
NZ230711A (en) * 1988-09-23 1990-10-26 Ortho Pharma Corp Substituted thienopyrans as antihypertensive agents
FR2639227A1 (en) * 1988-11-23 1990-05-25 Sanofi Sa USE OF CHROMANE DERIVATIVES FOR THE TREATMENT OF DEPRESSIVE STATES
GB8828679D0 (en) * 1988-12-08 1989-01-11 Beecham Group Plc Novel treatment
ES2071668T3 (en) * 1988-12-13 1995-07-01 Beecham Group Plc BENZOPYRAN AND RELATED COMPOUNDS.
TW224941B (en) * 1989-11-08 1994-06-11 Yamanouchi Pharma Co Ltd
WO1991009031A1 (en) * 1989-12-11 1991-06-27 Beecham Group Plc Trifluoromethyl substituted compounds and a pharmaceutical composition
US5401848A (en) * 1990-11-26 1995-03-28 E. R. Squibb & Sons, Inc. Indane and quinoline derivatives
NZ240933A (en) * 1990-12-21 1993-05-26 Ortho Pharma Corp Preparing enantiomerically pure thienopyran derivatives
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment

Also Published As

Publication number Publication date
JPH08504432A (en) 1996-05-14
EP0673248A1 (en) 1995-09-27
WO1994013292A1 (en) 1994-06-23

Similar Documents

Publication Publication Date Title
GB9215633D0 (en) Novel treatment
GB9208339D0 (en) Treatment composition
GB9127150D0 (en) Novel treatment
GB9226860D0 (en) Novel treatment
GB9211148D0 (en) Novel treatment
GB9203039D0 (en) Treatment
GB9225860D0 (en) Novel treatment
GB9226957D0 (en) Novel treatment
GB9226958D0 (en) Produktionsaktieselskab) novel treatment
AP9300527A0 (en) Novel treatment
GB9225859D0 (en) Novel treatment
GB9203637D0 (en) Novel treatment
GB9225948D0 (en) Novel treatment
GB9225964D0 (en) Novel treatment
GB9225862D0 (en) Novel treatment
GB9225863D0 (en) Novel treatment
GB9225881D0 (en) Novel treatment
GB9225858D0 (en) Novel treatment
GB9214209D0 (en) Novel treatment
GB9225956D0 (en) Novel treatment
GB9207219D0 (en) Novel treatment
GB9225957D0 (en) Novel treatment
GB9225959D0 (en) Novel treatment
GB9225961D0 (en) Novel treatment
GB9225963D0 (en) Novel treatment